- Improvement of Polymorphonuclear Functions in Dialysed Patients Treated with Recombinant Human Erythropoietin Need Not to be Dependent on Serum Ferritin Decrease1991 | Second Faculty of Medicine
- Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin2018 | First Faculty of Medicine
- Clinical and economic significance of consistent iron substitution in recombinant human erythropoietin therapy of anaemia in haemodialysis patients2001 | Third Faculty of Medicine, Faculty of Arts
- Therapeutical approaches in anemia of prematurity2009 | First Faculty of Medicine
- Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact2010 | First Faculty of Medicine
- Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study2003 | Second Faculty of Medicine
- A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease2009 | Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Pure red cell aplasia duting erythropoietin therapy in patiens with end stage renal disease2003 | Faculty of Medicine in Pilsen
- Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact2010 | Publication without faculty affiliation
- "Doping" case of R. K.: What are biologic passports?2017 | Faculty of Medicine in Pilsen
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publication without faculty affiliation